When is chemotherapy recommended for glioblastoma?

Glioblastoma is treated with a coordinated plan rather than one treatment in isolation. If surgery has removed as much visible tumour as safely possible, a cancer team may recommend chemotherapy with radiotherapy to address glioma cells that cannot be seen on scans. A further course may follow the combined treatment. The choice depends on the tumour’s laboratory findings, its location, what surgery achieved, your age, general health, medicines and recovery after the operation. Chemotherapy may be adjusted or postponed if swallowing, mobility, blood counts or other health concerns make treatment harder to tolerate.

Treatment is usually organised in cycles, with appointments and monitoring between them. The team may check blood counts and review symptoms before giving the next dose. Chemotherapy is intended to control remaining or returning disease; it does not replace discussions about surgery, radiotherapy, rehabilitation or supportive care.

Ask for a treatment meeting once the surgical and pathology information is available. Bring a current medicine list and mention seizures, steroid use, headaches, weakness, nausea or changes in concentration. Ask how chemotherapy fits with radiotherapy, how it will be given, which monitoring visits are needed and what support is available for fatigue, nausea, appetite changes or low blood counts. Keep a written record of doses, symptoms and temperature, and do not change seizure or steroid medicines without guidance.

Contact the oncology team promptly for a fever, repeated vomiting, unusual bleeding, severe new headache, worsening weakness, confusion, a seizure or difficulty staying awake. A sudden seizure, collapse, severe breathing difficulty or rapidly worsening neurological change needs emergency care. These symptoms can have several causes, including treatment effects or swelling, so urgent assessment is safer than waiting for the next appointment.

Which tumour findings affect the recommendation? Is chemotherapy planned with radiotherapy, afterward, or only if the tumour returns? How will you monitor blood counts and brain-related symptoms? Which warning signs should lead me to call the team the same day?